MedTech Company | AI & Robotics Systems for Hair Restoration | 22 Granted Patents | 100% YOY Growth | FDA Class 1 Devices | Proprietary Technology

Deal Pipe® presents a 7-year-old MedTech company leading the development of AI and Robotics-assisted systems in the field of hair restoration. Their focus is clear: building high-precision devices that combine robotics, artificial intelligence, and augmented reality to improve the quality, speed, and consistency of medical procedures. With over 22 granted patents, a proven track record, and continuous product demand, this business stands out as a pioneer in technology-driven healthcare.

Overview and Product Offering

Founded in 2018, this company has experienced rapid growth, achieving 100% year-over-year revenue growth. Their focus is on robotic and AI-assisted hair transplant systems, built under a proprietary product line that simplifies complex medical procedures for clinics. Each system comes with advanced software that automates the extraction and implantation process, allowing physicians to perform faster and more precise treatments. The average deal size for their systems is about $110,000, with strong margins supported by smart manufacturing practices and minimal overhead.

Their core devices are designed and assembled at their facility in Florida, where they can currently produce two to three fully operational units per day. About 80% of their components are locally sourced, giving them reliable supply control and shorter lead times. Every system is equipped with modular hardware and self-diagnostic tools, so most servicing needs can be resolved remotely, reducing downtime for their clients.

The company’s flagship products, including state-of-the-art robotic and AI-automated hair transplant systems, are celebrated for their unique features and comprehensive support offerings, setting them apart from competitors. These systems are designed to cater to a wide range of clients, from physicians to entrepreneurs, offering advanced solutions in hair restoration.

What Sets This Business Apart

This company is among the few in the market that combine robotics, AI, and AR in one complete platform. These systems are FDA Class 1 (510k exempt) devices and hold strong intellectual property protection across all models. Each product is built with attention to detail, offering precision, speed, and better patient outcomes compared to competing systems.

Their devices are not only cost-effective for clinics but also more advanced than leading alternatives in the market. Competitors typically require higher consumable costs and offer fewer features at higher price points. These advantages have helped the company build long-term relationships with medical professionals who rely on their technology. Their strategic initiatives and growth plans have positioned them well for future expansion, with an eye on international markets in the coming years.

How They’ve Grown

This company’s growth has been steady and organic, driven by word of mouth, training workshops, and professional referrals rather than heavy marketing. With a simple one-time purchase model supported by training, certification, and optional software upgrades, the brand continues to grow its network of clinics and practitioners across the United States.

The founder is a board-certified surgeon and technologist, bringing years of expertise in both clinical practice and product design. The founder’s involvement in research and development ensures that each product update reflects real-world clinical needs. The founder remains open to continuing as a consultant or partner after the acquisition, providing a buyer with access to valuable technical knowledge and ensuring smooth operational continuity.

Opportunities for a New Buyer

This business is built to scale. The production process can easily support more units per day through automation, and the company’s strong IP foundation makes expansion into international markets a clear next step. Markets such as Canada, Mexico, Brazil, and the EU have already shown demand for AI-integrated medical devices, giving a buyer multiple entry points for global growth.

There’s also significant room to grow through recurring revenue opportunities. The company’s proprietary software can transition into a subscription-based model, offering clinics ongoing access to updates, analytics, and support. Their training and certification programs, already active under established brands, continue to generate high-intent leads and build loyalty among medical professionals.

With strong margins, zero debt, and a product line proven in both clinical and commercial settings, this business offers a solid opportunity for a buyer seeking a ready-to-scale MedTech company backed by real technology, not concepts.

Business Broker Takeaways

1. High-Growth MedTech Platform. 100% YoY revenue growth, 80–85% gross margins, and over 22 granted patents demonstrate strong fundamentals and scalability in a $5.7B global market projected to grow sevenfold by 2032.

2. Scalable Global Expansion. Ready for international roll-out, with strong market traction in the U.S. and clear pathways into high-demand regions such as Canada, Brazil, Mexico, and the EU. Infrastructure and IP protections are already in place to support global growth.

3. Multiple Revenue Streams. Beyond device sales, the company drives additional revenue through training and certification programs and turnkey clinic solutions both of which strengthen customer retention and recurring income potential.

This business exemplifies innovation and strategic growth, making it an enticing opportunity for buyers in the medical device sector.

This MedTech Business is Represented by:

Deal Pipe.com

Technology Business Brokers

WC 3832